Antiretroviral therapy outcomes of HIV-infected children in the TREAT Asia pediatric HIV observational database

Journal of Acquired Immune Deficiency Syndromes

Volumn 55, Issue 4, 2010, Pages 503-509

  Hansudewechakul, Rawiwan ^a   Sirisanthana, Virat ^b   Kurniati, Nia ^c   Puthanakit, Thanyawee ^d   Lumbiganon, Pagakrong ^e   Saphonn, Vonthanak ^f   Yusoff, Nik Khairulddin Nik ^g   Kumarasamy, Nagalingeswaran ^h   Fong, Siew Moy ⁱ   Nallusamy, Revathy ^j   Srasuebkul, Preeyaporn ^k   Law, Matthew ^k   Sohn, Annette H ^l   Chokephaibulkit, Kulkanya ^m  

^a CHIANGRAI PRACHANUKROH HOSPITAL   (Thailand)

^b CHIANG MAI UNIVERSITY   (Thailand)

^c CIPTO MANGUNKUSUMO HOSPITAL   (Indonesia)

^d THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^e KHON KAEN UNIVERSITY   (Thailand)

^f National Center for HIV/AIDS   (Cambodia)

^g HOSPITAL RAJA PEREMPUAN ZAINAB II   (Malaysia)

^h YRG CENTRE FOR AIDS RESEARCH AND EDUCATION   (India)

ⁱ Hospital Likas   (Malaysia)

^j Penang Adventist Hospital   (Malaysia)

^k UNIVERSITY OF NEW SOUTH WALES   (Australia)

^l TREAT Asia/amfAR The Foundation for AIDS Research   (Thailand)

^m MAHIDOL UNIVERSITY   (Thailand)

more..

Author keywords

antiretroviral therapy; Asia; outcomes; pediatric HIV

Indexed keywords

CD4 ANTIGEN;

ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; CHILD; DATA BASE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; TREATMENT OUTCOME; VIRUS LOAD;

ADOLESCENT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ASIA; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; HIV INFECTIONS; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 78650237129     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181f5379a     Document Type: Article

References (26)

1. UNAIDS, WHO. AIDS Epidemic Update: December 2009. Geneva, Switzerland: UNAIDS, WHO 2009.
2. UNICEF. Children and AIDS, Fourth Stocktaking Report. UNICEF; 2009.
3. WHO. Antiretroviral Therapy of HIV Infection in Infants and Children in Resource-Limited Settings: Towards Universal Access, Recommendations for a Public-Health Approach. WHO 2006.
4. Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359: 2233-2244.
5. Kariminia A, Chokephaibulkit K, Pang J, et al. Cohort Profile: The TREAT Asia Pediatric HIV Observational Database. Int J Epidemiol. 2010. [Epub ahead of print].
6. Prasitsuebsai W, Bowen AC, Pang J, et al. Pediatric HIV clinical care resources and management practices in Asia: a regional survey of the TREAT Asia pediatric network. AIDS Patient Care STDS. 2009;24:127-131.
7. WHO. WHO growth chart 2006. Available at: http://www.who.int/ childgrowth/en/. Accessed September 8, 2010.
8. Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11. 2002(246):1-190.
9. Puthanakit T, Kerr S, Ananworanich J, et al. Pattern and predictors of immunologic recovery in human immunodeficiency virus-infected children receiving non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy. Pediatr Infect Dis J. 2009;28:488-492.
10. Soh CH, Oleske JM, Brady MT, et al. Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents. Lancet. 2003;362:2045-2051.
11. WHO. Report of the WHO Technical Reference Group, Paediatric HIV/ ART Care Guideline Group Meeting WHO Headquarters. Geneva, Switzerland: WHO; April 10-11, 2008.
12. O'Brien DP, Sauvageot D, Zachariah R, et al. In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy. AIDS. 2006;20:1955-1960.
13. Zhang F, Haberer JE, Zhao Y, et al. Chinese pediatric highly active antiretroviral therapy observational cohort: a 1-year analysis of clinical, immunologic, and virologic outcomes. J Acquir Immune Defic Syndr. 2007;46:594-598.
14. McConnell MS, Byers RH, Frederick T, et al. Trends in antiretroviral therapy use and survival rates for a large cohort of HIV-infected children and adolescents in the United States, 1989-2001. J Acquir Immune Defic Syndr. 2005;38:488-494.
15. Selik RM, Lindegren ML. Changes in deaths reported with human immunodeficiency virus infection among United States children less than thirteen years old, 1987 through 1999. Pediatr Infect Dis J. 2003; 22:635-641.
16. Kline MW, Rugina S, Ilie M, et al. Long-term follow-up of 414 HIV-infected Romanian children and adolescents receiving lopinavir/ ritonavir-containing highly active antiretroviral therapy. Pediatrics. 2007; 119:e1116-1120.
17. Ciaranello AL, Chang Y, Margulis AV, et al. Effectiveness of pediatric antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis. Clin Infect Dis. 2009;49:1915-1927.
18. Jaspan HB, Berrisford AE, Boulle AM. Two-year outcomes of children on non-nucleoside reverse transcriptase inhibitor and protease inhibitor regimens in a South African pediatric antiretroviral program. Pediatr Infect Dis J. 2008;27:993-998.
19. Lapphra K, Vanprapar N, Chearskul S, et al. Efficacy and tolerability of nevirapine- versus efavirenz-containing regimens in HIV-infected Thai children. Int J Infect Dis. 2008;12:e33-e38.
20. Benjamin DK Jr, Miller WC, Benjamin DK, et al. A comparison of height and weight velocity as a part of the composite endpoint in pediatric HIV. AIDS. 2003;17:2331-2336.
21. Puthanakit T, Aurpibul L, Oberdorfer P, et al. Sustained immunologic and virologic efficacy after four years of highly active antiretroviral therapy in human immunodeficiency virus infected children in Thailand. Pediatr Infect Dis J. 2007;26:953-956.
22. Sutcliffe CG, van Dijk JH, Bolton C, et al. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis. 2008;8:477-489.
23. WHO, UNAIDS, UNICEF. Towards Universal Access: Scaling up Priority HIV/AIDS Interventions in the Health Sector, Progress Report 2009. WHO 2009.
24. Janssens B, Raleigh B, Soeung S, et al. Effectiveness of highly active antiretroviral therapy in HIV-positive children: evaluation at 12 months in a routine program in Cambodia. Pediatrics. 2007;120:e1134-e1140.
25. Kamya MR, Mayanja-Kizza H, Kambugu A, et al. Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy. J Acquir Immune Defic Syndr. 2007;46:187-193.
26. KIDS-ART-LINC. Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in Sub-Saharan africa. J Acquir Immune Defic Syndr. 2008;49:523-531.